Curcumin supplementation significantly lowered alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in nonalcoholic fatty liver disease (NAFLD), with pooled mean differences of −5.61 and −3.90 units/L, respectively, indicating improved liver function (Lukkunaprasit et al. 2023). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.